Eric is a Venture Partner at Revelation Partners. He brings multiple decades of experience in healthcare as an investor and a scientist. At Revelation Partners he focuses on identifying and leading new investment opportunities with an emphasis on biopharma and medical devices.

Prior to Revelation Partners Eric was a Partner at DCVC Bio where he led investments in early-stage biotechnology companies. Previously, he was a Partner at Novo Ventures where he established and managed the firm’s public equities strategy focused on smidcap and late-stage private companies in therapeutics and medical devices. Earlier in his career Eric was a Director at Apposite Capital focused on healthcare secondaries and an Associate at Burrill & Company, a life sciences venture capital firm. Having initially trained as a structural biologist, he served as a Leukemia & Lymphoma Society Post-Doctoral Fellow.

Eric received a B.A. in Biophysics from the Johns Hopkins University and a Ph.D. in Molecular Biology from Princeton University. Outside of work, Eric enjoys spending time with his wife and three children, rooting for the Texas Longhorns and training for whatever race is next weekend.